Biologic response modifier therapy for psoriatic ocular inflammatory disease

N Huynh, RA Cervantes-Castañeda… - Ocular Immunology …, 2008 - Taylor & Francis
Purpose: To evaluate the efficacy and safety of biologic response modifiers (BRMs) in the
treatment of patients with psoriatic ocular inflammatory disease. Methods: The records of 8 …
Save Cite Cited by 85 Related articles

[CITATION][C] Biologic Response Modifier Therapy for Psoriatic Ocular Inflammatory Disease

N Huynh, RA Cervantes-Castañeda, P Bhat… - Ocular Immunology and …, 2008 - cir.nii.ac.jp
Biologic Response Modifier Therapy for Psoriatic Ocular Inflammatory Disease | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Cite

Biologic response modifier therapy for psoriatic ocular inflammatory disease

N Huynh, RA Cervantes-Castaneda… - Ocular …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose To evaluate the efficacy and safety of biologic response modifiers (BRMs) in the
treatment of patients with psoriatic ocular inflammatory disease. Methods The records of 8 …
Cite

Biologic response modifier therapy for psoriatic ocular inflammatory disease.

N Huynh, RA Cervantes-Castaneda, P Bhat… - Ocular Immunology …, 2008 - europepmc.org
Purpose To evaluate the efficacy and safety of biologic response modifiers (BRMs) in the
treatment of patients with psoriatic ocular inflammatory disease. Methods The records of 8 …
Cite